Alignment Healthcare (ALHC)
(Delayed Data from NSDQ)
$13.51 USD
+0.01 (0.07%)
Updated Jan 14, 2025 04:00 PM ET
After-Market: $13.54 +0.03 (0.22%) 7:58 PM ET
3-Hold of 5 3
C Value A Growth C Momentum B VGM
Price, Consensus and EPS Surprise
ALHC 13.51 +0.01(0.07%)
Will ALHC be a Portfolio Killer in January?
Zacks Investment Research is releasing its prediction for ALHC based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for ALHC
GeneDx Holdings (WGS) Surges 13.2%: Is This an Indication of Further Gains?
Compared to Estimates, Alignment Healthcare (ALHC) Q3 Earnings: A Look at Key Metrics
ALHC: What are Zacks experts saying now?
Zacks Private Portfolio Services
Alignment Healthcare (ALHC) Reports Q3 Loss, Tops Revenue Estimates
Earnings Preview: Organon (OGN) Q3 Earnings Expected to Decline
Alignment Healthcare (ALHC) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
Other News for ALHC
Alignment Healthcare’s Promising Growth and Profitability Outlook: A Buy Recommendation by Whit Mayo
ALHC Crosses Above Average Analyst Target
Alignment Healthcare price target raised to $16 from $14 at Stifel
Alignment Healthcare price target raised by $2 at Stifel, here's why
Alignment Healthcare: Strategic Growth and Competitive Edge Justify Buy Rating